M&A Deal Summary |
|
|---|---|
| Date | 2012-07-25 |
| Target | HCP Packaging |
| Sector | Packaging |
| Buyer(s) | TPG |
| Deal Type | Buyout (LBO, MBO, MBI) |
| Deal Value | 500M USD |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1992 |
| PE ASSETS | 296.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
TPG Capital is a global, mega-sized private investment firm that manages a family of funds focused on private equity, real estate, venture capital, public equity and debt investing. TPG invests in opportunities across a broad range of industries and geographies. TPG generally seeks to invest in established businesses that can benefit from the Firm's operational experience and connections. Industries of interest include consumer, retail, healthcare, industrials, digital media, natural resources, energy, real estate, technology, and software. TPG was formerly known as Texas Pacific Group and was originally established in 1992 by David Bonderman, James Coulter and William Price. The Firm is based in Forth Worth, Texas with additional offices in Europe, Asia, and Australia.
| DEAL STATS | # |
|---|---|
| Overall | 194 of 453 |
| Sector: Packaging M&A | 4 of 4 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 28 of 53 |
| Country: China M&A | 13 of 20 |
| Year: 2012 M&A | 6 of 10 |
| Size (of disclosed) | 92 of 114 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-07-21 |
Fenwal
Lake Zurich, Illinois, United States Fenwal, Inc. is one of the world's largest suppliers of products and services to the transfusion medicine industry. Fenwal was created with a single purpose: to provide high quality, innovative blood collection and processing products and services that support customers' missions to improve and save lives. |
Sell | $1.1B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-08-07 |
Ultragenyx
Novato, California, United States Ultragenyx is a biopharmaceutical company committed to bringing to market novel products to treat rare and ultra-rare diseases, focusing on serious, debilitating genetic diseases. Ultragenyx was founded in 2010 and is based in Novato, California. |
Buy | - |